Cyprotex
Cyprotex was a contract research organisation specialising in in-vitro and in-silico ADME-tox testing. It was a leading outsource provider of such services to the pharmaceutical industry. It also provided in-vitro toxicity testing to the cosmetics and agrochemical industries. The company operated laboratories in both the UK and the US.
The business was sold to a large German drug discovery and development company.
![Cyprotex logo](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/09/CRX-logo-2988-x-720.png)
Fund
Fund 3
Investment date
September 2013
Deal type
PIPE
Sector
Life sciences
Exit date
December 2016
Exit type
Trade sale
![Examining cells](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/09/unnamed-scaled-1.webp)
![scientific results being stored](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/09/DSC0082-scaled-1.webp)
![Scientific testing equipment](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/09/6Y9C5828.webp)
![City and trees](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/11/harwood_aerial_cropped.png)